*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
R75 - Inconclusive laboratory evidence of human immunodeficiency virus [HIV] - as a primary or secondary diagnosis code | ||
---|---|---|
OUTCOMES | ||
Avg. LOS | ||
Readmission Rate (%) | ||
Unplanned Readmission Rate (%) | 19.3 | |
Mortality Rate (%) | ||
SNF Discharge Rate (%) | ||
Home Discharge Rate (%) | ||
PAYMENTS AND CHARGES | ||
Total Medicare Payments | ||
Payment Per Day | ||
Payment Per Hospitalization | ||
Total Medicare Charges | ||
Avg. Charges | ||
MARKET SIZING & INCIDENCE RATES | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations after Exclusion |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 885: PSYCHOSES | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|
Total Hospitalizations at DRG | 1,100,860 | |
Total Hospitalizations with ICD R75 - Inconclusive laboratory evidence of human immunodeficiency virus [HIV] | 22 | |
DRG Share of Total Hospitalizations | 3.35 | |
% of Total ICD R75 - Inconclusive laboratory evidence of human immunodeficiency virus [HIV] in DRG | 11.76 | |
Avg LOS at DRG | 11.86 | |
Avg LOS with ICD R75 - Inconclusive laboratory evidence of human immunodeficiency virus [HIV] | 8.45 | |
Readmission Rate at DRG | 27.58 | |
Readmission Rate with ICD R75 - Inconclusive laboratory evidence of human immunodeficiency virus [HIV] | NA | |
Unplanned Readmission Rate at DRG | 13.34 | |
Unplanned Readmission Rate with ICD R75 - Inconclusive laboratory evidence of human immunodeficiency virus [HIV] | NA | |
Total Medicare payments at DRG | $9,312,828,663 | |
Total Medicare payments with ICD R75 - Inconclusive laboratory evidence of human immunodeficiency virus [HIV] | $160,537 | |
Total Medicare payment per Day at DRG | $713 | |
Total Medicare payment per Day with ICD R75 - Inconclusive laboratory evidence of human immunodeficiency virus [HIV] | $863 | |
Total Medicare payment per Hospitalization at DRG | $8,460 | |
Total Medicare payment per Hospitalization with ICD R75 - Inconclusive laboratory evidence of human immunodeficiency virus [HIV] | $7,297 | |
Total Medicare Charges at DRG | $32,341,464,302 | |
Total Medicare Charges with ICD R75 - Inconclusive laboratory evidence of human immunodeficiency virus [HIV] | $434,632 | |
Avg Charges at DRG | $29,378 | |
Avg Charges with ICD R75 - Inconclusive laboratory evidence of human immunodeficiency virus [HIV] | $19,756 | |
Mortality Rate at DRG | 0.04 | |
Mortality Rate with ICD R75 - Inconclusive laboratory evidence of human immunodeficiency virus [HIV] | NA | |
SNF Discharge Rate at DRG | 5.83 | |
SNF Discharge Rate with ICD R75 - Inconclusive laboratory evidence of human immunodeficiency virus [HIV] | NA | |
Home Discharge Rate at DRG | 79.47 | |
Home Discharge Rate with ICD R75 - Inconclusive laboratory evidence of human immunodeficiency virus [HIV] | 72.73 |